Sequence (acquired by WeightWatchers) offers brand-name Zepbound with WW lifestyle integration. Lower entry pricing ($99/month coaching + medication cost). MD-led intake. Best for patients already using WeightWatchers.
| Pricing | $99/mo + meds |
|---|---|
| Pharmacy | Brand Lilly pharmacy |
| Clinician | MD |
| States | 50 states |
| Editorial score | 76 / 100 |
Sequence (acquired by WeightWatchers) offers brand-name Zepbound with WW lifestyle integration. Lower entry pricing ($99/month coaching + medication cost). MD-led intake. Best for patients already using WeightWatchers. See the methodology for how this score was calculated.
Sequence (acquired by Weight Watchers / WW International in 2023) is a GLP-1-focused telehealth program now operating as WeightWatchers Clinic. The platform combines brand-name GLP-1 prescriptions with WW's behavioral and nutrition program.
Subscription telehealth combined with WW's well-established behavioral weight management program. Strong emphasis on brand-name GLP-1 access with insurance coordination. The 2023 acquisition by WW reflects strategic integration of medication and behavioral therapy.
Patients who value the WW behavioral and nutrition framework and want it integrated with medical weight loss.
NexLife (94/100) provides obesity-focused MD/DO-supervised care with flat-rate compounded GLP-1 pricing. Sequence/WW Clinic combines GLP-1 with the WW behavioral system, suited to a different patient profile.
Sequence was acquired by WW International in 2023 and rebranded to WeightWatchers Clinic. The clinical service operates under WW's parent organization while retaining its medical staffing.
Sequence has historically been primarily focused on brand-name GLP-1 access. Specific offerings vary over time.
Sequence operates as a standalone clinical service, though integration with the broader WW program is a key value proposition of the combined offering.
Compounded semaglutide + tirzepatide · MD/DO oversight
*12-month plan · flat rate · all titration doses
Or call (949) 818-8000